Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Introduction by the Guest Editor

At a Crossroad to Cure

From Molecule to Management Strategies in Multiple Myeloma

Munshi, Nikhil C., MD

doi: 10.1097/PPO.0000000000000357
Review Articles

From the Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, and VA Boston Healthcare System, Harvard Medical School, Boston, MA.

Conflicts of Interest and Source of Funding: N.C.M. is a consultant for Celgene, Takeda, Janssen, Oncopep, and Merck. This work was supported by the National Institutes of Health grant P01-155258-07.

Reprints: Nikhil C. Munshi, MD, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215. E-mail: Nikhil_munshi@dfci.harvard.edu.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.